When infected with high-risk HPV, the first step is to determine which subtype is infected. If the infection is high-risk HPV subtypes 16 and 18, it is recommended that a timely colposcopic cervical biopsy be performed, and based on the pathologic results of the cervical biopsy, the next step in the treatment plan will be decided. For other subtypes of infection, it can be combined with TCT co-screening, and if the TCT is negative, the HPV test can be repeated in six months or a year. There is a chance that a person will be infected with high-risk HPV throughout his or her life, but the virus can be cleared by improving his or her immunity, such as exercising to strengthen the body’s resistance, and by using some antiviral drugs, such as interferon suppositories, anti-HPV bioprotein dressings, and Rebifen, which can be used to clear up the virus.